Eli Lilly to Build Six U.S. Plants, Says Trump; LLY Up on Expansion Plans

President Donald Trump announced on January 29, 2026, that Eli Lilly (LLY) plans to construct six new U.S. manufacturing facilities, citing a conversation with the company’s CEO. Trump called the executive “a star” during a White House cabinet meeting. Eli Lilly previously committed to investing at least $27 billion to build four U.S. plants—already announcing locations in Alabama, Virginia, and Texas—to expand drug production and strengthen domestic supply chains. The company has not confirmed the additional two facilities mentioned by Trump and did not immediately respond to requests for comment.